Juvisé Pharmaceuticals acquires global rights (excluding US/Canada) to PONVORY® and opens its capital to Bpifrance and Pemberton

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur pretium tristique maximus. Mauris ullamcorper faucibus arcu et bibendum. Donec auctor rutrum tristique. Sed justo velit, tempus eu hendrerit semper, ultricies non sapien. Suspendisse vel eros eget eros facilisis tincidunt sit amet ac augue.